Skip to main content

Table 2 IHC and FISH results of MET according to the status of PR receptor in DIC carcinomas

From: FISH and immunohistochemical status of the hepatocyte growth factor receptor (c-Met) in 184 invasive breast tumors

 

ER+/PR+ (n = 46)

ER+/PR- (n = 34)

 

IHC

IHC

IHC

IHC

FISH MET

Negative

Positive

Negative

Positive

FISH Negative

27 (59%)

12 (26%)

9 (23%)

13 (38%)

FISH Polysomy

4 (9%)

3 (6%)

3 (9%)

10 (29%)

  1. DIC, ductal infiltrating carcinoma; ER, estrogen receptor; FISH, fluorescent in situ hybridization; IHC, immunohistochemistry; P, polysomy; PR, progesterone receptor. In bold we remark the FISH and IHQ positive results to compare both groups.